3Wolthers OD,Pedersen S.Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids[J].Pediatrics,1992,89(5):839.
4van Staa TP,Leufkens HG,Cooper C.The epidemiology of corticosteroid-induced osteoporosis:a meta-analysis[J].Osteoporos Int,2002,13:777-787.
5Saito JK,Davis JW,Wasnich RD,et al.Users of low-dose glucocorticoids have increased bone loss rates:a longitudinal study[J].Calcif Tissue Int,1995,57:115-119.
6Ducharme FM,Chabot G,Polychronakos C,et al.Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma:impact on bone metabolism,bone density,and adrenal[J].Pediatrics,2003,111:376-383.
7Ishizuka T,yoshii A,Tsukagoshi H,et al.Effects of fluticasone propionate on bone mineral density in patients with persistent bronchial asthma[J].Intem Med,2002,41:798-804.
8Langhammer A,Norjavaara E,de Verdier MG,et al.Use of inhaled corticosteroids and bone mineral density in a population based study:the Nord-Trondelag Health Study the HUNT study[J].Pharmacoepidemiol Drug Saf,2004,13:569-579.
9Wong CA,Walsh LJ,Smith CJ,et al.Inhaled corticosteroid use and bone mineral density in patients with asthma[J].Lancet,2000,355:1399-1403.
10Leone FT,Fish JE,Szefler SJ,et al.Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma[J].Chest,2003,124:2329-2340.
